Editor: Atta-ur-Rahman

Frontiers in Clinical Drug Research - HIV

Volume 3

eBook: US $100 Special Offer (PDF + Printed Copy): US $169
Printed Copy: US $119
Library License: US $400
ISSN: 2468-0397 (Print)
ISSN: 2352-5916 (Online)
ISBN: 978-1-68108-230-1 (Print)
ISBN: 978-1-68108-229-5 (Online)
Year of Publication: 2016
DOI: 10.2174/97816810822951160301

Introduction

Frontiers in Clinical Drug Research – HIV is an eBook series that brings updated reviews to readers interested in learning about advances in the development of pharmaceutical agents for the treatment of acquired immune deficiency syndrome (AIDS) and other disorders associated with human immunodeficiency virus (HIV) infection. The scope of the eBook series covers a range of topics including the medicinal chemistry and pharmacology of natural and synthetic drugs employed in the treatment of AIDS (including HAART) and resulting complications, and the virology and immunological study of HIV and related viruses. Frontiers in Clinical Drug Research – HIV is a valuable resource for pharmaceutical scientists, clinicians and postgraduate students seeking updated and critically important information for developing clinical trials and devising research plans in HIV/AIDS research.

The third volume of this series features 5 chapters that cover a variety of topics including:

  • - Studies of HPV infections in HIV positive people
  • - Allosteric Integrase Inhibitors
  • - HAART
  • - Drugs targeting various types HIV-1 enzymes

Preface

- Pp. i
Atta-ur-Rahman
Download Free

List of Contributors

- Pp. ii
Atta-ur-Rahman
Download Free

Human Papillomavirus in HIV Positive People

- Pp. 3-48 (46)
Anna Rosa Garbuglia
View Abstract

Allosteric Integrase Inhibitors

- Pp. 49-126 (78)
Victoria Hann, Peter Dawson, Mark Ashton
View Abstract

HAART: A Boon to Mankind

- Pp. 127-162 (36)
Silpi Basak
View Abstract

The Current Progress and Challenge in the Development of Entry Inhibitors of HIV-1

- Pp. 163-184 (22)
Chang Liu, Xiaohong Kong
View Abstract

Prospects of Reverse Transcriptase Inhibitors

- Pp. 185-209 (25)
Chang Liu, Xiaohong Kong
View Abstract

HIV-1 Integrase Inhibitors: Targets and Clinical Application

- Pp. 210-237 (28)
Chang Liu, Xiaohong Kong
View Abstract

The Current Progress and Challenge in the Development of Protease Inhibitors of HIV-1

- Pp. 238-264 (27)
Chang Liu, Xiaohong Kong
View Abstract

Blocking HIV-1 Replication via Targeting the Tatmediated Transcriptional Machinery

- Pp. 265-285 (21)
Chang Liu, Xiaohong Kong
View Abstract

Subject Index

- Pp. 286-295 (10)
Atta-ur-Rahman
Download Free

RELATED BOOKS

.COVID 19 – Monitoring with IoT Devices.
.Recent Advances in the Application of Marine Natural Products as Antimicrobial Agents.
.Recent Trends and The Future of Antimicrobial Agents - Part 2.
.COVID-19: Origin, Impact and Management (Part 1).